LOBBYIST

Juan Machado

← Back to lobbyists

14ACTIVITIES
1ORGS REPRESENTED
1BILLS

Revolving door — covered positions

Federal positions Juan held before / during the 2-year LDA window. This is the credibility signal — who they were inside the building before they started lobbying it.

Senate Finance Committee
Professional Staff and Senior Health Advisor, Department of Health & Human Services, Health Insurance Specialist

Organizations represented

1

Orgs whose LD-2 filings list Juan as an active lobbyist, sorted by activity volume.

Eli Lilly and Company14 activities

Bills they file on

1
H.R. 53764 mentions

Topics in Filings

24

Policy topics Juan files on across all their LD-2 activities.

Intellectual property×4
340B Program×4
Canada IP×2
USMCA implementation×2
Mexico patent linkage×2
Show all 24 topics (+19 more) ▾
Special 301×2
Trade talks: US-Japan×2
US-India, and US-Brazil×2
US Tariffs×2
Patient protection×2
Pharmaceutical supply chain issues×2
Drug pricing, coverage, value, access and quality×2
Health insurance accessibility×2
Prescription drug approval×2
CMS National Coverage Determination on Alzheimer's disease×2
Multi-lateral threats to IP and the biopharmaceutical industry×2
Drug importation×2
Prescription drug value, access and quality×2
Pharmaceutical intellectual property issues×2
Domestic manufacturing tax incentives×2
Expensing of research and development costs×2
Global minimum tax×2
Pension and retirement benefit issues×2
Hospital discounts×2

Pulled from the org’s own LD-2 disclosures. See the source filings ↓

Issue mix

LDA general-issue codes weighted by activity count.

Trade (domestic/foreign)2
Health Issues2
Medicare/Medicaid2
Consumer Issues/Safety/Products2
Copyright/Patent/Trademark2
Taxation/Internal Revenue Code2
Pharmacy2